InMed Pharmaceuticals Inc. (OTCMKTS:IMLFF – Get Free Report)’s share price traded down 4.5% on Wednesday . The company traded as low as $3.65 and last traded at $3.79. 77,046 shares traded hands during trading, an increase of 578% from the average session volume of 11,369 shares. The stock had previously closed at $3.97.
InMed Pharmaceuticals Trading Down 4.5 %
The stock’s fifty day moving average price is $4.63 and its two-hundred day moving average price is $1.94.
About InMed Pharmaceuticals
InMed Pharmaceuticals Inc, a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain.
Further Reading
- Five stocks we like better than InMed Pharmaceuticals
- Dividend Payout Ratio Calculator
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Investing In Automotive Stocks
- 3 Steel Stocks Soaring After Tariff Announcements
- What Are Some of the Best Large-Cap Stocks to Buy?
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for InMed Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMed Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
